Trial To Evaluate Anti-fibrinolytic Therapy In Thrombocytopenia (TREATT)
Funder
National Health and Medical Research Council
Funding Amount
$1,057,478.00
Summary
Patients with haematologic malignancies often have low platelet counts from their disease or treatment. This can be associated with bleeding, which can sometimes be serious or fatal. Nearly 2/3 of all platelet transfusions in Australia are given in this setting to try to prevent bleeding but many people still experience bleeding. This study asks whether tranexamic acid can safely & effectively reduce bleeding and if it does, does reduced bleeding lead to reduction in platelet transfusions?